Healthcare-associated infections in Australia: Time for national surveillance

Australian Health Review

Volumn 39, Issue 1, 2015, Pages 37-43

  Russo, Philip L ^a   Cheng, Allen C ^b,c   Richards, Michael ^d   Graves, Nicholas ^a   Hall, Lisa ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Infection Prevention and Healthcare Epidemiology Unit Alfred Health   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CROSS INFECTION; HEALTH SURVEY; HUMAN;

AUSTRALIA; CROSS INFECTION; HUMANS; POPULATION SURVEILLANCE;

EID: 84922277794     PISSN: 01565788     EISSN: 14498944     Source Type: Journal    
DOI: 10.1071/AH14037     Document Type: Article

References (54)

1. National Health and Medical Research Council. Australian guidelines for the prevention and control of infection in healthcare. Canberra: Commonwealth of Australia; 2010.
2. Burke JP. Infection control: a problem for patient safety. N Engl J Med 2003; 348: 651-6. doi:10.1056/NEJMhpr020557
3. Goto M, Al-Hasan MN. Overall burden of bloodstream infect ion and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 2013; 19: 501-9. doi:10.1093/cid/cit737
4. Graves N, Halton K, Paterson D, Whitby M. Economic rationale for infection control in Australian hospitals. Healthc Infect 2009; 14: 81-8. doi:10.1071/HI09010
5. Allen-Bridson K, Morrell GC, Horan TC. Surveillance of healthcareassociated infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. 4th edn. Philadelphia: Wolters Kluwer; 2012. pp. 1329-43.
6. Australian Commission on Safety and Quality in Health Care. Standard 3. Preventing and controlling hospital acquired infection. Sydney: Commonwealth of Australia; 2012.
7. Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. Estimating the proportion of healthcare-Associated i nfections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol 2011; 32: 101-14. doi:10.1086/657912
8. Harbarth S, Sax H, Gastmeier P. The preventab le proportion of nosocomial infections: an overview of published reports. J Hosp Infect 2003; 54: 258-66. doi:10.1016/S0195-6701(03)00150-6
9. Wilson J, Wloch C, Saei A, McDougall C, Harringto n P, Charlett A, Lamagni T, Elgohari S, Sheridan E. Inter-hospital comparison of rates of surgical site infection following caesarean section delivery: evaluation of a multicentre surveillance study. J Hosp Infect 2013; 84: 44-51. doi:10.1016/j.jhin.2013.01.009
10. Haley RW. The scientific basis for using surveillance and risk factor data to reduce nosocomial infection rates. J Hosp Infect 1995; 30(Suppl.): 3-14. doi:10.1016/0195-6701(95)90001-2
11. Edmond MB. National and international surveillance systems for nosocomial infections. In: Wenzel RP, editor. Prevention and control of nosocomial infections. 4th edn. Philadelphia: Lippincott Williams & Wilkins; 2003. pp. 109-19.
12. Garcia-Abren A, Halperin W, Danel I. Public health surveillance toolkit. Washington, DC: The World Bank; 2002.
13. Perl TM, Chaiwarth R. Surveillance: an overview. In: Lautenbach E, Woeltje KF, Malani PN, editors. Practical healthcare epidemiology. 3rd edn. London: The University of Chicago Press; 2012. p. 111-42.
14. Reilly J, Stewar t S, Allardice G, Cairns S, Ritchie L, Bruce J. Evidencebased infection control planning based on national healthcare-Associated infection prevalence data. Infect Control Hosp Epidemiol 2009; 30: 187-9. doi:1 0.1086/593125
15. Centers for Diseas e Conrtol and Prevention. Facilities in these states are required by law to reportHAI data toNHSN2014. Available at: http://www.cdc.gov/hai/stateplans/required-to-report-hai-NHSN.html [verified 11 July 2014].
16. Public Health England. Mandatory surveillance of Staphypococcus aureus bacteraemia. 2014. Available at: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/StaphylococcusAureus/EpidemiologicalData/MandatorySurveillance/[verified 11 July 2014].
17. Berrí ios-Torres SI,MuY, Edwards JR, Horan TC, Fridkin SK. Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections. Infect Control Hosp Epidemiol 201 2; 33: 463-9. doi:10.1086/665313
18. Haustein T, Gastmeier P, Holmes A, Lucet J-C, Shannon RP, Pittet D, Harbarth S. Use of benchmarking and public reporting for infection control in four hi gh-income countries. Lancet Infect Dis 2011; 11: 471-81. doi:10.1016/S1473-3099(10)70315-7
19. Rosenthal VD, Ramachandran B, Villamil-Gomez W, Armas-Ruiz A, Navoa-Ng JA, Matta-Cortes L, Pawar M, Nevzat-Yalcin A, Rodríguiez-Ferrer M, Yildizdąs RD, Menco A, Campuzano R, Villanueva VD, Rendon-Campo LF, Gupta A, Turhan O, Barahona-Guzmán N, Horoz OO, Arrieta P, Brito JM, TolentinoMCV,Astu dillo Y, Saini N, Gunay N, Sarmiento-Villa G, Gumus E, Lagares-Guzmán A, Dursun O. Impact of a multidimensional infection control strategy on central line-Associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC). Infection 2012; 40: 415-23. doi:10.1007/s15010-012-0246-5
20. Australian Commission on Safety and Quality in Health Care. National surveillance initiative. Sydney: National Surveillance Initiative 2013.
21. Richards C, Emori TG, Edwards J, Fridkin S, Tolson J, Gaynes R. Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. Am J Infect Control 2001; 29: 400-3. doi:10.1067/mic.2001. 118408
22. Edwards JR, Po llock DA, Kupronis BA, Li W, Tolson JS, Peterson KD, Mincey RB, Horan TC. Making use of electronic data: the National Healthcare Safety Network eSurveillance initiative. Am J Infect Control 2008; 36(Suppl.): S21-6. doi:10.1016/j.ajic.2007.07.007
23. Centers for Disease Control and Prevention. Monitoring hospital-Acquired infections to promote patient safety: United States, 1990-1999. MMWR Morb Mortal Wkly Rep 2000; 49: 149-53.
24. Gaynes R, Richards C, Edwards J, Emori TG, Horan T, Alonso-Echanove J, Fridkin S, Lawton R, Peavy G, Tolson J. National Nosocomial Infections Surveillance System Hospitals. Feeding back surveillance data to prevent hospital-Acquired infections. Emerg Infect Dis 2001; 7: 295-8. doi:10.3201/eid0702.010230
25. Gastmeier P, Sohr D, Schwab F, Behnke M, Zuschneid I, Brandt C, Dettenkofer M, Chaberny IF, Rü den H, Geffers C. Ten years of KISS: the most important requirements for success. J Hosp Infect 2008; 70(Suppl.): 11-6. doi:10.1016/S0195-6701(08)60005-5
26. CookeEM, Coello R, Sedgwick J, Ward V, Wilson J, Charlett A, Ward B, Pearson A. A national surveillance scheme for hospita l associated infections in England. J Hosp Infect 2000; 46: 1-3. doi:10.1053/jhin. 2000.0801
27. Gudiol F, Limón E, Fondevilla E, Argimon JM, Almirante B, Pujol M. The development and succ essful implementation of the VINCat Program. Enferm Infecc Microbiol Clin 2012; 30(Suppl. 3): 3-6. doi:10. 1016/S0213-005X(12)70089-7
28. Pé rez CD, Rodela AR, Monge Jodrá V. Quality Control Indicator Working Group. The Spanish national health care-Associated infection surveillance network (INCLIMECC): data summary January 1997 through December 2006 adapted to the new National Healthcare Safety Network Procedure-Associated module codes. Am J Infect Control 2009; 37: 806-12. doi:10.1016/j.ajic.2009.03.005
29. Rioux C, Grandbastien B, Astagneau P. Impact of a six-year control programme on surgical site infections in France: results of the INCISO surveillance. J Hosp Infect 2007; 66: 217-23. doi:10.1016/j. jhin.2007. 04.005
30. Reilly J, Cairns S, Fleming S, Hewitt D, Lawder R, Robertson C, et al. Results from the second Scottish national prevalence survey: the changing epidemiology of healthcare-Associated infection in Scotland. J Hosp Infect 2012; 82: 170-4. doi:10.1016/j.jhin.2012.07.024
31. Coello R, Gastmeier P, de Boer A. Surveillance of hospital-Acquired infection in England, Germany, a nd the Netherlands: will international comparison of rates be possible Infect Control Hosp Epidemiol 2001; 22: 393-7. doi:10.1086/501923
32. Gastmeier P. European perspective on surveillance. J Hosp Infect 2007; 65(Suppl. 2): 159-64. doi:10.1016/S0195-6701(07)60036-X
33. Geubbels ELPE, Bakker HG, Houtman P, van Noort-Klaassen MA, Pelk MSJ, Sassen TM, Wille JC. Promoting quality throu gh surveillance of surgical site infections: five prevention success stories. Am J Infect Control 2004; 32: 424-30. doi:10.1016/j.ajic.2004.07.001
34. Grammatico-Guillon L, Rusch E, Astagneau P. Surveillance of prosthetic joint infections: international overview and new insights for hospital databases. J Hosp Infect 2013, In press. doi:10.1016/j.jhin.2013.09.016
35. van Mourik MS, Troelstra A, van Solin ge WW, Moons KG, Bonten MJ. Automated surveillance for healthcare-Associated infections: opportunities for improvement. Clin Infect Dis 2013; 57: 85-93. doi:10.1093/cid/cit185
36. Gaynes RP. Surveillance of nosocomial infections: a fundamental ingredient for quality. Infect Control Hosp Epidemiol 1997; 18: 475-8. doi:10.2307/30141186
37. Hota B, Lin M, Doherty JA, Borlawsky T, W oeltje K, Stevenson K, Khan Y, Young J, Weinstein RA, Trick W. CDC Prevention Epicenter Program. Formulation of a model for automating infection surveillance: algorithmic detection of central-line associated bloodstream infection. J Am Med Inform Assoc 2010; 17: 42-8. doi:10.1197/jamia.M3196
38. Lin MY, Hota B, Khan YM, Woeltje KF, Borlawsky TB, Doherty JA, Stevenson KB, Weinstein RA, Trick WE. CDC Prevention Epicenter Program. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010; 304: 2035-41. doi:10.1001/jama.2010.1637
39. Freeman R, Moo re LS, Garcia Alvarez L, Charlett A, Holmes A. Advances in electronic surveillance for healthcare-Associated infections in the 21st century: a systematic review. J Hosp Infect 2013; 84: 106-19. doi:10.1016/j.jhin.2012.11.031
40. McLaws ML, Taylor PC. The Hospital Infection Standardised Surveillance (HISS) programme: analysis of a two-year pilot. J Hosp Infect 2003; 53: 259-67. doi:10.1053/jhin.2002.1361
41. Morton AP, Clements ACA, Doidge SR, Stackelroth J, Curits M, Whitby M. Surveillance of healthcare-Acquired infections in Queensland, Australia: data and lessons from the first 5 years. Infect Control Hosp Epidemiol 2 008; 29: 695-701. doi:10.1086/589904
42. Russo PL,Bull A,Bennett N,Boardman C,Burrell S,Motley J,Berry K,Friedman ND,Richards M The establishment of a statewide surveillanc e program for hospital-Acquired infections in large Victorian public hospitals: a report from the VICNISS Coordinating Centre AmJ Infect Control 2006 34 430-6 10.1016/j.ajic.2005.06.013
43. Van Gessel H, McCann RL, Peterson AM, Goggin LS. Validation of healthcare associated Staphylococcus aureus bloodstream infection surveillance in Western Australia. Healthc Infect 2010; 15: 21-5. doi:10.1071/HI09028
44. Richards MJ, Russo PL. Surveillance of hospital-Acquired infections in Australia: one nation, many states. J Hosp Infect 2007; 65(Suppl.): 174-81. doi:10.1016/S0195-6701(07) 60039-5
45. Friedman ND, Russo PL, Bull AL, Richards MJ, Kelly H. Validation of coronary artery bypass graft surgical site infection surveillance data from a statewide surveillance system in Australia. Infect Control Hosp Epidemiol 2007; 28: 812-7. doi:10.1086/518455
46. Goggin LS, van Gessel H, McCann RL, Peterson AM, Van Buynder PG. Validation of surgical site infection surveillance in Perth, Western Australia. Healthc Infect 2009; 14: 101-7. doi:10.1071/HI09113
47. McBryde ES, Brett J, Russo PL, Worth LJ, Bull AL, Richards MJ. Validation of statewide surveillance system dat a on central line-Associated bloodstream infection in intensive care units in Australia. Infect Control Hosp Epidemiol 2009; 30: 1045-9. doi:10.1086/606168
48. Australian Institute of Health and Welfare. MyHospitals. Available at: http://www.myhospitals.gov.au [verified 15 March 2013].
49. Cheng AC, Woolnough E, Worth LJ, Pilcher DV. How should we interpret hospital infection statistics? Med J Aust 2013; 199: 735-6. doi:10.5694/mja13.10703
50. Worth LJ, Thursky KA, Slavin MA. Public disclosure of health careassociated infections in Australia: quality improvement or parody? Med J Aust 2012; 1 97: 29. doi:10.5694/mja12.10466
51. Worth LJ, Bull AL, Richards MK. Public reporting of health careassociated infection data in Australia: time to refine. Med J Aust 2013; 198: 252-3. doi:10.5694/mja12.11317
52. Shaban RZ, Cruickshank M, Christiansen K and the Antimicrobial Resistance Standing Committee. National surveillance and reporting of antimicrobial resistance and antibiotic usage for human health in Australia. Antimicrobial Resistance Standing Committee, Australian Heath Protection Principal Committee: Canberra; 2013.
53. Cardo D, Dennehy PH, Halverson P, Fishman N, Kohn M, Murphy CL, Whitley RJ. HAI Elimination White Paper Writing Group. Moving toward elimination of healthcare-Associated infections: a call to action. Infect Control Hosp Epidemiol 2010; 31: 1101-5. doi:10.1086/656912
54. Mitchell BG, Gardner A. A model for influences on reliable and valid health care-Associated infection data. Am J Infect Control 2014; 42: 190-2. doi:10.1016/j.ajic.2013.08.002